Joan K Morris
Morris, J. (Joan), Dr.
VIAF ID: 51203466 (Personal)
Permalink: http://viaf.org/viaf/51203466
Preferred Forms
- 100 0 _ ‡a Joan K Morris
- 100 1 _ ‡a Morris, J. ‡q (Joan), ‡c Dr.
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
In vivo T1 values from guinea pig brain depend on body temperature | |
Incidence Oftesticular Cancer | |
Increasing body weight: 1989-2008. | |
Increasing incidence of tuberculosis in England and Wales: a study of the likely causes. | |
Inhibin-A in Down's syndrome pregnancies: revised estimate of standard deviation | |
Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study | |
Investigation of EEG Activity Compared with Mean Arterial Blood Pressure in Extremely Preterm Infants. | |
Is cascade testing a sensible method of population screening? | |
Is the prevalence of Klinefelter syndrome increasing? | |
Is there evidence of clustering in Down syndrome? | |
Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies | |
Long-term survival of children born with congenital anomalies: A systematic review and meta-analysis of population-based studies | |
Loss of employment and mortality. | |
Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. | |
Management and outcomes of neonates with down syndrome admitted to neonatal units | |
Maternal age in the epidemiology of common autosomal trisomies | |
Maternal age-specific fetal loss rates in Down syndrome pregnancies | |
Meta-analysis audit trail | |
A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk | |
Mortality from aortic stenosis: prospective study of serum calcium and phosphate. | |
Mortality from hypertrophic cardiomyopathy in England and Wales: clinical and screening implications | |
Mortality in relation to tar yield of cigarettes: a prospective study of four cohorts. | |
The Need to Interpret the Results of a Clinical Trial in the Context of Other Evidence | |
Newer anticonvulsants: Lamotrigine | |
De novo apparently balanced translocations in man are predominantly paternal in origin and associated with a significant increase in paternal age. | |
De novo deletions and duplications detected by array CGH: a study of parental origin in relation to mechanisms of formation and size of imbalance | |
Occupational Exposure to Hydrazine and Subsequent Risk of Lung Cancer: 50-Year Follow-Up | |
Oral anticoagulant agent-associated bleeding events reporting system (ORANGE) study. | |
Paternal age and birth defects: how strong is the association | |
Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study. | |
Personalized medicine: hope or hype | |
The population impact of screening for Down syndrome: audit of 19 326 invasive diagnostic tests in England and Wales in 2008. | |
Prenatal screening for serious congenital heart defects using nuchal translucency: a meta-analysis | |
Prescription of antiepileptic medicines including valproate in pregnant women: A study in three European countries | |
Prescription of cardiovascular medication in children with congenital heart defects across six European Regions from 2000 to 2014: data from the EUROlinkCAT population-based cohort study | |
Prevalence and severity of dental fluorosis in four English cities. | |
Prevalence of microcephaly in Europe: population based study | |
Prevalence of neural tube defect pregnancies in England and Wales from 1964 to 2004 | |
Prevention of Late Onset Sepsis and Central-line Associated Blood Stream Infection in Preterm Infants | |
Prevention of neural tube defects: a cross-sectional study of the uptake of folic acid supplementation in nearly half a million women | |
Preventive Angioplasty in Myocardial Infarction | |
Public health failure in the prevention of neural tube defects: time to abandon the tolerable upper intake level of folate. | |
Quantifying the health benefits of chronic disease prevention: a fresh approach using cardiovascular disease as an example | |
Randomized Polypill crossover trial in people aged 50 and over | |
Rates of Down syndrome at the upper extreme of maternal age: considerations and recommendations in analysis | |
Recurrence risks for trisomies 13, 18, and 21 | |
Recurrences of free trisomy 21: analysis of data from the National Down Syndrome Cytogenetic Register. | |
Reducing the Risk of Multiple Births by Transfer of Two Embryos after in Vitro Fertilization | |
Reply | |
Risk Factor Models for Neurodevelopmental Outcomes in Children Born Very Preterm or With Very Low Birth Weight: A Systematic Review of Methodology and Reporting | |
Risk of a Down syndrome live birth in women 45 years of age and older | |
The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18 | |
Screening for future cardiovascular disease using age alone compared with multiple risk factors and age | |
Screening for malignant melanoma. | |
Screening for Neuroblastoma in Children | |
Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers | |
Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark | |
Serum Albumin and Mortality in the BUPA Study | |
Serum homocysteine and the severity of coronary artery disease | |
Size at birth, growth trajectory in early life, and cardiovascular and metabolic risks in early adulthood: EPICure study | |
Sources of T1 variance in normal human white matter. | |
Starting the polypill: the use of a single age cut-off in males and females | |
Survival of trisomy 18 (Edwards syndrome) and trisomy 13 (Patau Syndrome) in England and Wales: 2004-2011 | |
A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project | |
Trends in maternal age distribution and the live birth prevalence of Down's syndrome in England and Wales: 1938–2010. | |
Trisomy 21 mosaicism and maternal age. | |
Truncation limits for CT marker ratios in prenatal screening for Down syndrome | |
Urgent need for folic acid fortification of flour and grains: response to the 2019 UK Government's public consultation | |
Use of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study | |
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies | |
Use of hierarchical models to analyze European trends in congenital anomaly prevalence | |
Use of infectious disease surveillance reports to monitor the Zika virus epidemic in Latin America and the Caribbean from 2015 to 2017: strengths and deficiencies | |
Valproic acid monotherapy in pregnancy and major congenital malformations | |
The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia | |
Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation | |
What is Case—Finding? | |
When screening is still not enough | |
ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas | |
প্রত্যুত্তর |